Supernus Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:SUPN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Mar 26	SellUS$451,181	Todd Horich	Individual	8,273	US$55.00
06 Mar 26	SellUS$583,846	Georges Gemayel	Individual	10,882	US$53.71
22 Aug 25	SellUS$524,092	Timothy Dec	Individual	11,780	US$44.49
14 Aug 25	SellUS$315,133	Frederick Hudson	Individual	7,457	US$42.26

Insider Trading Volume

Insider Buying: SUPN insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of SUPN?
Owner Type	Number of Shares	Ownership Percentage
State or Government	15,490	0.0253%
Individual Insiders	2,513,458	4.1%
Hedge Funds	3,281,615	5.35%
Institutions	55,492,148	90.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 79.89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.2%	BlackRock, Inc.	8,735,529	US$440.8m	0.43%	0.01%
10.5%	The Vanguard Group, Inc.	6,048,496	US$305.2m	0.06%	no data
5.7%	Millennium Management LLC	3,281,615	US$165.6m	24.3%	0.11%
4.8%	Armistice Capital LLC	2,764,000	US$139.5m	-2.54%	3.57%
4.71%	Dimensional Fund Advisors LP	2,712,341	US$136.9m	-9.65%	0.02%
4.01%	Nomura Investment Management Business Trust	2,307,639	US$116.4m	-8.84%	0.16%
3.93%	Point72 Asset Management, L.P.	2,264,800	US$114.3m	28.6%	0.2%
3.85%	State Street Global Advisors, Inc.	2,219,228	US$112.0m	1.45%	no data
3.84%	Jack Khattar	2,212,178	US$111.6m	2.76%	no data
3.01%	Renaissance Technologies LLC	1,732,522	US$87.4m	-0.47%	0.14%
2.56%	Geode Capital Management, LLC	1,472,899	US$74.3m	4.46%	no data
2.52%	Loomis Sayles & Company, L.P.	1,448,842	US$73.1m	12.7%	0.1%
2.44%	Stephens Investment Management Group, LLC	1,406,522	US$71.0m	4.54%	0.98%
1.88%	GW&K Investment Management, LLC	1,080,716	US$54.5m	0.02%	0.47%
1.28%	Morgan Stanley	739,333	US$37.3m	74.9%	no data
1.23%	D. E. Shaw & Co., L.P.	707,982	US$35.7m	-27.7%	0.03%
1.22%	Charles Schwab Investment Management, Inc.	703,636	US$35.5m	-3.94%	no data
1.16%	Northern Trust Global Investments	670,413	US$33.8m	-4.71%	no data
1.06%	Ashford Capital Management Inc	612,538	US$30.9m	8.66%	3.84%
0.96%	Sofinnova Investment, Inc.	553,095	US$27.9m	46.7%	1.42%
0.91%	Victory Capital Management Inc.	526,220	US$26.6m	-6%	0.01%
0.84%	Pictet Asset Management Limited	483,399	US$24.4m	-5.02%	0.02%
0.81%	Rice Hall James & Associates, LLC	467,886	US$23.6m	-1.72%	1.36%
0.79%	Citadel Advisors LLC	452,959	US$22.9m	-68%	0.02%
0.69%	Goldman Sachs Asset Management, L.P.	399,284	US$20.1m	-59%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/13 08:05
End of Day Share Price	2026/03/13 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Supernus Pharmaceuticals, Inc. is covered by 17 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Emily Bodnar	Berenberg
Chi Meng Fong	BofA Global Research
Pavan Patel	BofA Global Research